Hyperfractionated radiotherapy for brain stem tumours in children.
From 1988 to 1992 in the Centre of Oncology, Warsaw, 42 children with brain stem tumours were treated with hyperfractionated radiotherapy (HFRT). Two-year survival in nine (27%) patients was obtained. The HFRT treated group was compared with the historical, conventionally irradiated group with the same diagnosis. The hyperfractionated radiotherapy was well tolerated, but did not improve survival rate in comparison with conventionally treated group.
Skowrońska-Gardas
A
A
First Radiotherapy Department, M. Skłodowska-Curie Memorial Institute, Warsaw, Poland.
D000293:Adolescent; D001254:Astrocytoma / Q000401:mortality / Q000532:radiotherapy*; D001932:Brain Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D001933:Brain Stem; D002648:Child; D002675:Child, Preschool; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D005260:Female; D005910:Glioma / Q000401:mortality / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D011867:Radioisotope Teletherapy / Q000379:methods*; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D015996:Survival Rate
D003037:Cobalt Radioisotopes